Clinical Immunology Review Series: An approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome

Clinical and Experimental Immunology

Volumn 156, Issue 1, 2009, Pages 1-11

  Keogan, M T ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Beh et's disease; Complex aphthosis; Recurrent aphthous stomatitis

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; BENZYDAMINE; CHLORHEXIDINE; COLCHICINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETANERCEPT; HYDROCORTISONE; INFLIXIMAB; LIDOCAINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PENTOXIFYLLINE; SALAZOSULFAPYRIDINE; STEROID; SUCRALFATE; TETRACYCLINE; THALIDOMIDE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

APHTHOUS STOMATITIS; APHTHOUS ULCER; ARTERY DISEASE; ARTERY SURGERY; ARTHROPATHY; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CLINICAL IMMUNOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EYE INFLAMMATION; FATIGUE; GASTROINTESTINAL DISEASE; GENITAL ULCER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPATHOGENESIS; KIDNEY DISEASE; LABORATORY TEST; MALAISE; MOUTH ULCER; NEUROLOGIC DISEASE; NEUROTOXICITY; PATHERGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SKIN DEFECT; SKIN DISEASE; VASCULAR DISEASE; VEIN DISEASE;

BEHCET SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; MALE; RECURRENCE; STOMATITIS, APHTHOUS; ULCER;

EID: 61849148340     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03857.x     Document Type: Article

References (110)

1. Scully C. Aphthous ulceration. N Engl J Med 2006 355 : 165 72.
2. Letsinger JA, McCarthy MA, Jorizzo JL. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol 2005 52 : 500 8.
3. Jorizzo JL, Taylor RS, Schmalstieg FC et al. Complex aphthosis: a forme fruste of Behçet's syndrome. J Am Acad Dermatol 1985 13 : 80 4.
4. Srinivasan U, Weir DG, Feighery C, O'Farelly C. Emergence of classic enteropathy after longstanding gluten sensitive oral ulceration. BMJ 1998 316 : 206 7.
5. Rogers RS. Recurrent aphthous stomatitis in the diagnosis of Behçet's disease. Yonsei Med J 1997 38 : 370 9.
6. Clinical Knowledge Summaries (CKS). Aphthous ulcer. Available at: http://cks.library.nhs.uk/aphthous-ulcer/view-whole-topic-review (accessed 29 December 2008).
7. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behçet's disease: an analysis of 2147 patients. Yonsei Med J 1997 38 : 423 7.
8. Bang D, Hur W, Lee ES, Lee S. Prognosis and clinical relevance of recurrent oral ulceration in Behçet's disease. J Dermatol 1995 22 : 926 9.
9. Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH. HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 2001 19 (Suppl. 24 S31 35.
10. Behçet H. Uber rezidivierende, aphthose, durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937 36 : 1152 7.
11. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl Med J 1999 341 : 1284 91.
12. Marshall SE. Behçet's disease. Clin Rheum 2004 18 : 291 311.
13. Alpsoy E, Donmez L, Bacanli A, Apaydin C, Butun B. Review of the chronology of clinical manifestations in 60 patients with Behçet's disease. Dermatology 2003 207 : 354 6.
14. International Study Group for Behçet's Disease Criteria for the diagnosis of Behçet's disease. Lancet 1990 335 : 1078 80.
15. Ferrez MB, Walter SC, Heymann R, Atra E. Sensitivity and specificity of different diagnostic criteria for Behçet's disease according to the latent class approach. Br J Rheumatol 1995 34 : 932 5.
16. Dervis E, Geyik N. Sensitivity and specificity of different diagnostic criteria for Behçet's disease in a group of Turkish patients. J Dermatol 2005 32 : 266 72.
17. Tunc R, Uluhan A, Melikoglu M, Ozyazgan Y, Ozdogan H, Yazici H. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behçet's syndrome. Clin Exp Rheumatol 2001 19 : S45 47.
18. Scully C, Boyle P, Yap PL. Immunoglobulins G, M, A, D and E in Behçet's disease. Clin Chim Acta 1982 120 : 237 42.
19. Muftuoglu AU, Yazici H, Yurdakul S et al. Behçet's disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 1986 25 : 235 9.
20. Aygunduz M, Bavbek N, Ozturk M, Kaftan O, Kosar A, Kirazli S. Serum beta 2-microglobulin reflects disease activity in Behçet's disease. Rheumatol Int 2002 22 : 5 8.
21. Coskun B, Saral Y, Godekmerdan A, Erden I, Coskun N. Activation markers in Behçet's disease. Skinmed 2005 4 : 282 6.
22. Main DM, Chamberlain MA. Clinical differentiation of oral ulceration in Behçet's disease. Br J Rheumatol 1992 31 : 767 70.
23. Krause I, Rosen Y, Kaplan I et al. Recurrent aphthous stomatitis in Behçet's disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med 1999 28 : 193 6.
24. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behçet's disease. Yonsei Med J 2007 48 : 573 85.
25. Zouboulis CC. Epidemiology of Adamantiades-Behçet's disease. Ann Med Interne (Paris) 1999 150 : 488 98.
26. Kontogiannis V, Powell RJ. Behçet's disease. Postgrad Med J 2000 76 : 629 37.
27. Kitaichi N, Miyazaki A, Stanford MR, Chams H, Iwata D, Shigeaki O. Ocular features of Behçet's disease: an international collaborative study. Br J Ophthalmol 2007 91 : 1579 82.
28. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 2004 138 : 373 80.
29. Alpsoy E, Aktekin M, Er H, Durusoy C, Yilmaz E. A randomized, controlled and blinded study of papulopustular lesions in Turkish Behçet's patients. Int J Dermatol 1998 37 : 839 42.
30. Kim B, LeBoit PE. Histopathologic features of erythema nodosum-like lesions in Behçet disease: a comparison with erythema nodosum focusing on the role of vasculitis. Am J Dermatopathol 2000 22 : 379 90.
31. Yaziki H, Chamberlain MA, Tuzun Y, Yurdakul S, Muftuoglu A. A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis 1984 43 : 74 5.
32. Davies PG, Fordham JN, Kirwan JR, Barnes CG, Dinning WJ. The pathergy test and Behçet's syndrome in Britain. Ann Rheum Dis 1984 43 : 70 3.
33. Dilsen N, Konice M, Aral O, Ocal L, Inanc M, Gul A. Comparative study of the skin pathergy test with blunt and sharp needles in Behçet's disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis 1993 52 : 823 5.
34. Fresko I, Yazici H, Bayramicli M, Yurdakul S, Mat C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet's syndrome. Ann Rheum Dis 1993 52 : 619 20.
35. Chang HK, Cheon KS. The clinical significance of a pathergy reaction in patients with Behçet's disease. J Korean Med Sci 2002 17 : 371 4.
36. Jorizzo JL, Solomon AR, Cavallo T. Behçet's syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 1985 109 : 747 51.
37. Kural-Seyahi E, Fresko I, Seyahi N et al. The longterm mortality and morbidity of Behcet's syndrome. A 2-decade outcome survey of 387 patients followed at a dedicated centre. Medicine 2003 82 : 60 76.
38. Zouboulis CC, Vaiopoulos G, Marcomichelakis N et al. Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece. Clin Exp Rheum 2003 21 : S19 S26.
39. Siva A, Altintas A, Saip S. Behçet's syndrome and the nervous system. Curr Opin Neurol 2004 17 : 347 57.
40. Akman-Demir G, Serdaroglu P, Tasci B for the Neuro-Behçet's Study Group. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 1999 122 : 2171 82.
41. Hirohata S. Histopathology of central nervous system lesions in Behçet's disease. J Neurol Sci 2008 267 : 41 7.
42. Akman-Demir G, Bahar S, Coban O, Tasci B, Seraroglu P. Cranial MRI in Behçet's disease: 134 examinations of 98 patients. Neuroradiology 2003 45 : 851 9.
43. Borhani Haghighi A, Aflaki E, Ketabchi L. The prevalence and characteristics of different types of headaches in patients with Behçet's disease, a case-control study. Headache 2008 48 : 424 9.
44. Akbutlut L, Gur G, Bodur H, Alli N, Borman P. Peripheral neuropathy in Behçet's disease: an electroneurophysiological study. Clin Rheumatol 2007 26 : 1240 4.
45. Alpsoy E, Donmez L, Onder M et al. Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study. Br J Dermatol 2007 157 : 901 6.
46. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004 126 : 1518 32.
47. Al-Otaibi LM, Porter SR, Poate TWJ. Behçet's disease: a review. J Dent Res 2005 84 : 209 22.
48. Koc Y, Gullu I, Akpek G et al. Vascular involvement in Behçet's disease. J Rheumatol 1992 19 : 402 10.
49. Yamato M, Lecky JW, Hiramatsu K, Kohda E. Takayasu arteritis: radiographic and angiographic findings in 59 patients. Radiology 1986 161 : 329 34.
50. Bonsib SM. Polyarteritis nodosa. Semin Diagn Pathol 2001 18 : 14 23.
51. Ortiz-Santamaria V, Olive A, Holgado S, Muchart J. Pulmonary aneurysms in microscopic polyangiitis. Clin Rheumatol 2003 22 : 498 9.
52. Akpolat T, Dilek M, Aksu K et al. Renal Behçet's disease: an update. Semin Arthritis Rheum 2008 38 : 241 8.
53. Utku U, Dilek M, Akpolat I, Bedir A, Akpolat T. SAA1 alpha/alpha alleles in Behçet's disease related renal amyloidosis. Clin Rheumatol 2007 26 : 927 9.
54. Melikoglu M, Altiparmak MR, Fresko I et al. A reappraisal of amyloidosis in Behçet's syndrome. Rheumatology 2001 40 : 212 15.
55. Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S. Renal Behçet's disease: a cumulative analysis. Semin Arthritis Rheum 2002 31 : 317 37.
56. Akpolat T, Diri B, Oguz Y, Yilmaz E, Yavuz M, Dilek M. Behçet's disease and renal failure. Nephrol Dial Transplant 2003 18 : 888 91.
57. Yurdakul s, Yazici H, Tuzun Y et al. The arthritis of Behçet's disease: a propective study. Ann Rheum Dis 1983 42 : 505 15.
58. Goto M, Koyama H, Takahashi O, Fukui T. A retrospective review of 226 hospitalised patients with fever. Intern Med 2007 46 : 17 22.
59. Yazici H, Basaran G, Hamurydan V et al. The ten-year mortality in Behçet's syndrome. Br J Rheumatol 1996 35 : 139 41.
60. Hatemi G, Silman A, Bang D et al. EULAR recommendations for the management of Behçet's disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2008 67 : 1656 62.
61. Sfikakis PP, Markomichelakis N, Alpsoy E et al. Anti-TNF therapy in the management of Behçet's disease - review and basis for recommendations. Rheumatology 2007 46 : 736 41.
62. Gul A. Standard and novel therapeutic approaches to Behçet's disease. Drugs 2007 67 : 2013 22.
63. Lin P, Liang G. Behçet disease. Recommendations for clinical management of mucocutaneous lesions. J Clin Rheumatol 2006 12 : 282 6.
64. Alder YD, Mansmann U, Zouboulis CC. Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease. Dermatology 2001 203 : 322 4.
65. Llinares-Tello F, Hernandez-Prats C, Munoz-Ruiz C, Selva-Otaolaurruchi J, Ordovas-Baines JP. Monitoring trough plasma concentrations of mycophenolate mofetil in patients with uveitis. J Clin Pharm Ther 2004 29 : 53 8.
66. Molloy ES, Powell FC, Doran MF et al. An unusual case of Behçet's syndrome: triggered by typhoid vaccination? Clin Exp Rheumatol 2004 22 (4 Suppl. 34 S71 4.
67. Statkute L, Oyama Y, Barr WG et al. Autologous non-myeloablative hematopoietic stem cell transplantation for refractory systemic vasculitis. Ann Rheum Dis 2008 67 : 991 7.
68. Maurer B, Hensel M, Max R, Fiehn C, Ho AD, Lorenz HM. Autologous haematopoietic stem cell transplantation for Behçet's disease with pulmonary involvement: analysis after 5 years of follow up. Ann Rheum Dis 2006 65 : 127 9.
69. Daikeler T, Kotter I, Bocelli Tyndall C et al. Haematopoietic stem cell transplantation for vasculitis including Behçet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature. Ann Rheum Dis 2007 66 : 202 7.
70. Azizlerli G, Kose AA, Sarica R et al. Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol 2003 42 : 803 6.
71. Kone-Paut I, Geisler I, Wechsler B et al. Familial aggregation in Behçet's disease: high frequency in siblings and parents of paediatric probands. J Pediatr 1999 135 : 89 93.
72. Molinari N, Kone-Paut I, Manna R, Demaille J, Daures JP, Touitou I. Identification of an autosomal recessive mode of inheritance in pediatric Behçet's families by segregation analysis. Am J Med Genet 2003 122A : 115 18.
73. Ochonisky S, Verroust J, Bastuli-Garin S, Gherardi R, Revuz J. Thalidomide neuropathy incidence and clinico-electrophysiological findings in 42 patients. Arch Dermatol 1994 130 : 66 9.
74. Hamuryudan V, Yurdakul S, Ozbakir F, Yazici H, Hekim H. Monozygotic twins concordant for Behçet's disease. Br J Rheumatol 1997 36 : 922 3.
75. Kobayashi T, Sudo Y, Okamura S et al. Monozygotic twins discordant for intestinal Behçet's disease. J Gastroenterol 2005 40 : 421 5.
76. Gul A, Inanc L, Ocal O, Aral M, Carin M, Konice M. HLA-B51 negative monozygotic twins discordant for Behçet's disease. Br J Rheum 1997 36 : 922 7.
77. Mizuki N, Ota N, Kimura M et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci USA 1997 94 : 1298 303.
78. Ahmad T, Wallace GR, James T et al. Mapping the HLA association in Behçet's disease. A role for tumor necrosis factor polymorphisms? Arthritis Rheum 2003 48 : 807 13.
79. Mizuki N, Ota N, Yabuki K et al. Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 2000 41 : 3702 8.
80. Mizuli N, Meguro A, Tohnai I et al. Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behçet's disease in Turkey. Jpn J Ophthalmol 2007 51 : 431 6.
81. Karasneh J, Gul A, Ollier WE, Silman AJ, Worthington J. Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum 2005 52 : 1836 42.
82. Ando S, Maemori M, Sakai H et al. Constitutional trisomy 8 mosaicism with myelodysplastic syndrome complicated by intestinal Behçet disease and antithrombin III deficiency. Cancer Genet Cytogenet 2005 162 : 172 5.
83. Gebreselassie D, Spiegel H, Vulmanovic S. Sampling of major histocompatibility complex class I-associated petidome suggests relatively looser global association of HLA-B5101 with peptides. Hum Immunol 2006 67 : 894 906.
84. Zierhut M, Mizuki N, Ohno S et al. Immunology and functional genomics of Behçet's disease. Cell Mol Life Sci 2003 60 : 1903 22.
85. Lee MT, Hooper LC, Kump L et al. Interferon-Β and adhesion molecules (E-selectin and s-intracellular adhesion molecule-1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling. Clin Exp Immunol 2007 147 : 71 80.
86. Marsal S, Falga C, Simeon CP, Liardell M, Bosch JA. Behçet's disease and pregnancy relationship study. Br J Rheum 1997 36 : 234 8.
87. Fam AG, Siminovitch KA, Carette S, From L. Neonatal Behçet's in an infant of a mother with the disease. Ann Rheum Dis 1981 40 : 509 12.
88. Fain O, Mathieu E, Lachassinne E et al. Neonatal Behçet's disease. Am J Med 1995 98 : 310 11.
89. Thivolet J, Cambazard F, Genvo MF. Grande aphtose neonatale de transmission maternelle [Maternally-transmitted severe neonatal aphthosis]. Ann Dermatol Venerol 1982 109 : 815 16.
90. Lewis MA, Priestley BL. Transient neonatal Behçet's disease. Arch Dis Child 1986 61 : 805 6.
91. Stark AC, Bhakta B, Chamberlain MA, Dear P, Taylor PV. Life threatening transient neonatal Behçet's disease. Br J Rheum 1997 36 : 700 2.
92. Okunuki Y, Usui Y, Takeuchi M et al. Proteomic surveillance of autoimmunity in Behçet's disease with uveitis: selenium binding protein is a novel autoantigen in Behçet's disease. Exp Eye Res 2007 84 : 823 31.
93. Margutti P, Matarrese P, Conti F et al. Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis. Blood 2008 111 : 4559 70.
94. Delunardo F, Conti F, Margutti P et al. Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease. Arthritis Res Ther 2006 8 : R71.
95. Yazici H, Pazarli H, Barnes CG et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990 322 : 281 5.
96. Hamuryudan V, Ozyazgan Y, Hizli N et al. Azathioprine in Behçet's syndrome: effects on long-term prognosis. Arthritis Rheum 1997 40 : 769 74.
97. Ozyazgan Y, Yurdakul S, Yazici H et al. Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial. Br J Ophthalmol 1992 76 : 241 3.
98. BenEzra D, Cohen E, Chajek T et al. Evaluation of conventional therapy versus cyclosporin A in Behçet's syndrome. Transplant Proc 1988 20 (3 Suppl. 4 136 43.
99. Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G. Double-masked trial of cyclosporin versus colchicines and longterm open study of cyclosporin in Behçet's disease. Lancet 1989 1 : 1093 6.
100. Alpsoy E, Durusoy C, Yilman E et al. Interferon alpha-2a in the treatment of Behçet's disease: a randomised placebo-controlled and double-blind study. Arch Dermatol 2002 138 : 467 71.
101. Kotter I, Gunaydin I, Zierhut M, Stubiger N. The use of interferon alpha in Behçet disease: review of the literature. Semin Arthritis Rheum 2004 33 : 320 35.
102. Cantini F, Salvarani C, Niccoli L et al. Treatment of thrombophlebitis of Behçet's disease with low dose cyclosponin A. Clin Exp Rheumatol 199 : 391 2.
103. Hamurydan V, Yurdakul S, Moral F et al. Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. Br J Rheumatol 1994 33 : 48 51.
104. Humurydan V, Er T, Seyahi E et al. Pulmonary aneurysms in Behçet's syndrome. Am J Med 2004 117 : 867 70.
105. Hirohata S, Suda H, Hashimotot T. Low dose weekly methotrexate for progressive neuropsychiatric manifestations of Behçet's disease. J Neurol Sci 1998 159 : 181 5.
106. Kikuchi H, Aramaki K, Hirohata S. Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years. Adv Exp Med Biol 2003 528 : 575 8.
107. Nicholas JC, Ince A, Akduman L, Mann ES. Interferon-alpha 2a treatment of neuro-Behçet's disease. J Neuroophthalmol 2001 21 : 109 11.
108. Iida M, Kobayashi H, Matsumoto T et al. Postoperative recurrence in patients with intestinal Behçet's disease. Dis Colon Rectum 1994 37 : 16 21.
109. Choi IJ, Kim JS, Cha SD et al. Longterm clinical course and prognostic factors in intestinal Behçet's disease. Dis Colon Rectum 2000 43 : 692 70.
110. Brik R, Shamali H, Bergman R. Successful thalidomide treatment of severe infantile Behçet disease. Pediatr Dermatol 2001 18 : 143 5.